Compare GraniteShares 2x Long COIN Daily ETF (CONL) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GraniteShares 2x Long COIN Daily ETF vs Medpace Holdings Inc — how do they compare? GraniteShares 2x Long COIN Daily ETF trades at $5.26 (market cap $510.01M), while Medpace Holdings Inc trades at $612.05 (market cap $16.82B). The key difference: Medpace Holdings Inc is far larger — about 33× GraniteShares 2x Long COIN Daily ETF's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, GraniteShares 2x Long COIN Daily ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold GraniteShares 2x Long COIN Daily ETF for 15 Days and Medpace Holdings Inc for 14 Days on average.
| CONL | MEDP | |
|---|---|---|
Market Cap | $510.01M | $16.82B |
Volume | 21,041,836 | 223,093 |
Sector | Leveraged / Inverse | Health |
52-Week High | $41.19 | $630.19 |
52-Week Low | $3.93 | $393.42 |
Typical Hold Time | 15 Days | 14 Days |
Enterprise Value | — | $16.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CONL, the GraniteShares 2x Long COIN Daily ETF, trades at $4.85, down 7.27% with bearish technical signals from moving averages. The ETF provides leveraged exposure to Coinbase stock, experiencing significant volatility as highlighted in recent financial media coverage. Key oscillators show oversold conditions with RSI readings below 22, suggesting potential for near-term bounce.
The outlook remains challenging given the leveraged structure's sensitivity to Coinbase volatility. Investment opportunity exists for tactical traders betting on Coinbase recovery, but risks include amplified losses during downtrends and the structural decay inherent in daily reset leveraged products.
Medpace (MEDP) trades at $602.70, down slightly by 0.26% on the day, with a neutral technical outlook and bullish moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue and net income are projected to grow in 2026, supported by a robust 17.67% net income margin and exceptional ROE of 162.15%. However, valuation ratios like P/E of 35.41 and P/B of 38.77 suggest a premium pricing relative to peers.
The stock offers upside to the consensus price target of $620.44, but risks include high valuation multiples, CEO stock sales, and mixed institutional positioning. Investors should weigh strong profitability against potential overvaluation and monitor Q3 earnings for continued momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About GraniteShares 2x Long COIN Daily ETF
CONL is a leveraged ETF that seeks to provide two times (2x) the daily performance of Coinbase Global (COIN) stock. It is designed for investors seeking magnified short-term exposure to the price movements of Coinbase.
Read more on CONL →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
